138 related articles for article (PubMed ID: 17900833)
1. Disodium norcantharidate loaded poly(epsilon-caprolactone) microspheres I. Preparation and evaluation.
Wang S; Guo S; Cheng L
Int J Pharm; 2008 Feb; 350(1-2):130-7. PubMed ID: 17900833
[TBL] [Abstract][Full Text] [Related]
2. Disodium norcantharidate-loaded poly(epsilon-caprolactone) microspheres II. Modification of morphology and release behavior.
Wang S; Guo S
Int J Pharm; 2008 Apr; 353(1-2):15-20. PubMed ID: 18083314
[TBL] [Abstract][Full Text] [Related]
3. Formation mechanism and release behavior of poly(epsilon-caprolactone) microspheres containing disodium norcantharidate.
Wang S; Guo S
Eur J Pharm Biopharm; 2008 Aug; 69(3):1176-81. PubMed ID: 18430549
[TBL] [Abstract][Full Text] [Related]
4. The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug.
Hombreiro Pérez M; Zinutti C; Lamprecht A; Ubrich N; Astier A; Hoffman M; Bodmeier R; Maincent P
J Control Release; 2000 Apr; 65(3):429-38. PubMed ID: 10699300
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization and in vitro release properties of ibuprofen-loaded microspheres based on polylactide, poly(epsilon-caprolactone) and their copolymers.
Zhu KJ; Li Y; Jiang HL; Yasuda H; Ichimaru A; Yamamoto K; Lecomte P; Jerome R
J Microencapsul; 2005 Feb; 22(1):25-36. PubMed ID: 16019888
[TBL] [Abstract][Full Text] [Related]
6. Formulation and in vitro characterization of rifampicin-loaded porous poly (ε-caprolactone) microspheres for sustained skeletal delivery.
Mei Q; Luo P; Zuo Y; Li J; Zou Q; Li Y; Jiang D; Wang Y
Drug Des Devel Ther; 2018; 12():1533-1544. PubMed ID: 29910601
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase inhibitor loaded PCL microspheres prepared by S/O/W technique using ethanol as pretreatment agent.
Zhang Y; Zhang Y; Guo S; Huang W
Int J Pharm; 2009 Mar; 369(1-2):19-23. PubMed ID: 19041382
[TBL] [Abstract][Full Text] [Related]
8. Effects of crystalline microstructure on drug release behavior of poly(epsilon-caprolactone) microspheres.
Jeong JC; Lee J; Cho K
J Control Release; 2003 Oct; 92(3):249-58. PubMed ID: 14568406
[TBL] [Abstract][Full Text] [Related]
9. Full factorial design optimization of anti-inflammatory drug release by PCL-PEG-PCL microspheres.
Azouz L; Dahmoune F; Rezgui F; G'Sell C
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():412-9. PubMed ID: 26478328
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization and in vitro drug release of poly-epsilon-caprolactone and hydroxypropyl methylcellulose phthalate ketoprofen loaded microspheres.
Guzman M; Molpeceres J; Garcia F; Aberturas MR
J Microencapsul; 1996; 13(1):25-39. PubMed ID: 8903783
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyapatite-armored poly(ε-caprolactone) microspheres and hydroxyapatite microcapsules fabricated via a Pickering emulsion route.
Fujii S; Okada M; Nishimura T; Maeda H; Sugimoto T; Hamasaki H; Furuzono T; Nakamura Y
J Colloid Interface Sci; 2012 May; 374(1):1-8. PubMed ID: 22364710
[TBL] [Abstract][Full Text] [Related]
13. The microencapsulation of protein using a novel ternary blend based on poly(epsilon-caprolactone).
Huatan H; Collett JH; Attwood D
J Microencapsul; 1995; 12(5):557-67. PubMed ID: 8544099
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of aligned porous poly(ε-caprolactone) (PCL)/hydroxyapatite (HA) composite microspheres.
Kim MJ; Koh YH
Mater Sci Eng C Mater Biol Appl; 2013 May; 33(4):2266-72. PubMed ID: 23498257
[TBL] [Abstract][Full Text] [Related]
15. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
16. Protein release from poly(epsilon-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study.
Jameela SR; Suma N; Jayakrishnan A
J Biomater Sci Polym Ed; 1997; 8(6):457-66. PubMed ID: 9151193
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of felodipine-located poly(epsilon-caprolactone) microspheres.
Kim BK; Hwang SJ; Park JB; Park HJ
J Microencapsul; 2005 Mar; 22(2):193-203. PubMed ID: 16019904
[TBL] [Abstract][Full Text] [Related]
18. Release behaviour of carbamazepine-loaded poly(ε-caprolactone)/poly(ethylene oxide) microspheres.
Pepic D; Nikolic MS; Grujic S; Lausevic M; Djonlagic J
J Microencapsul; 2013; 30(2):151-60. PubMed ID: 22852775
[TBL] [Abstract][Full Text] [Related]
19. Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles.
Misra R; Acharya S; Dilnawaz F; Sahoo SK
Nanomedicine (Lond); 2009 Jul; 4(5):519-30. PubMed ID: 19572818
[TBL] [Abstract][Full Text] [Related]
20. Formulation of spray-dried phenytoin loaded poly(epsilon-caprolactone) microcarrier intended for brain delivery to treat epilepsy.
Li Z; Li Q; Simon S; Guven N; Borges K; Youan BB
J Pharm Sci; 2007 May; 96(5):1018-30. PubMed ID: 17455322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
